Presidents of National Academy of Medicine and National Academy of Sciences Present new initiative on ethics of human gene editing technology
Victor J. Dzau, MD, President of the National Academy of Medicine, and Ralph J. Cicerone, PhD, President of the National Academy of Sciences, emphasize the great promise that new, more powerful and efficient genome editing techniques such as CRISPR/Cas9 hold for improving human health and boosting food production in their Editorial “Responsible Use of Human Gene-Editing Technologies” in a special issue of Human Gene Therapy devoted to genome editing.
Use of these innovative molecular tools to modify human germline DNA, however, raises technical, social, and ethical issues that will be the focus of a multidisciplinary, international initiative led by the Academies, as described in the Editorial published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
The article is available free on the Human Gene Therapy website until October 15, 2015.
“The Academies have a history of providing leadership on emerging and controversial technologies,” state Drs. Dzau and Cicerone. “In keeping with these efforts, we are prepared to undertake this initiative to provide a comprehensive understanding of human genome editing and its implications.”
Responsible Use of Human Gene-Editing Technologies Dzau Victor J. and Cicerone Ralph J.. Human Gene Therapy. July 2015, 26(7): 411-412. doi:10.1089/hum.2015.29004.vjd.